Cargando…
Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma
BACKGROUND: Potential epigenetic biomarkers for malignant transformation to carcinoma ex pleomorphic adenoma (Ca ex PSA) have been sought previously with and without specific comparison with the benign variant, pleomorphic salivary adenoma (PSA). Previous analysis has been limited by a non-quantitat...
Autores principales: | Schache, A G, Hall, G, Woolgar, J A, Nikolaidis, G, Triantafyllou, A, Lowe, D, Risk, J M, Shaw, R J, Liloglou, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008600/ https://www.ncbi.nlm.nih.gov/pubmed/21063414 http://dx.doi.org/10.1038/sj.bjc.6605953 |
Ejemplares similares
-
BRCA1/2 Mutations in Salivary Pleomorphic Adenoma and Carcinoma-ex-Pleomorphic Adenoma
por: Irani, Soussan, et al.
Publicado: (2017) -
CD44 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma and their adjacent normal salivary glands
por: Shamloo, Nafiseh, et al.
Publicado: (2018) -
Immunohistochemical Expression of p53 in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma
por: Tarakji, Bassel, et al.
Publicado: (2010) -
Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
por: Suzuki, Takayoshi, et al.
Publicado: (2021) -
Pleomorphic adenoma of the buccal salivary gland
por: Khandekar, Shubhangi, et al.
Publicado: (2015)